CN Patent

CN113194929B — Glp-1肽的喷雾干燥工艺

Assigned to Novo Nordisk AS · Expires 2022-12-09 · 3y expired

What this patent protects

本发明涉及包含GLP‑1肽司美格鲁肽的进料溶液的喷雾干燥工艺，其中雾化气体流速(kg/h)与进料溶液流速(kg/h)之比为1.0‑1.7。

USPTO Abstract

本发明涉及包含GLP‑1肽司美格鲁肽的进料溶液的喷雾干燥工艺，其中雾化气体流速(kg/h)与进料溶液流速(kg/h)之比为1.0‑1.7。

Drugs covered by this patent

Patent Metadata

Patent number
CN113194929B
Jurisdiction
CN
Classification
—
Expires
2022-12-09
Drug substance claim
No
Drug product claim
No
Assignee
Novo Nordisk AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.